including TP53 mutation and complex karyotypes, gene mutations that typically have a poor prognosis due to their aggressive disease course and treatment resistance Phase 1 continues with a new stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback